271
Views
19
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Comparison of Level of NKG2D Ligands between Normal and Tumor Tissue Using Multiplex RT-PCR

, M.S., , M.D., , M.S., , M.S., , M.S., , M.D., , M.D., Ph.D., , M.D., Ph.D., , M.D., Ph.D., , M.D., Ph.D., , Ph.D., , Ph.D. & , M.D., Ph.D. show all
Pages 299-307 | Published online: 11 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Roberto Cascone, Annalisa Carlucci, Matteo Pierdiluca, Mario Santini & Alfonso Fiorelli. (2017) Prognostic value of soluble major histocompatibility complex class I polypeptide-related sequence A in non-small-cell lung cancer – significance and development. Lung Cancer: Targets and Therapy 8, pages 161-167.
Read now
Min-Ju Park, Jae-Ho Bae, Joo Seop Chung, Sun-Hee Kim & Chi-Dug Kang. (2011) Induction of NKG2D Ligands and Increased Sensitivity of Tumor Cells to NK Cell-mediated Cytotoxicity by Hematoporphyrin-based Photodynamic Therapy. Immunological Investigations 40:4, pages 367-382.
Read now

Articles from other publishers (17)

Young Shin Lee, Hojung Choi, Hae-Ryung Cho, Woo-Chang Son, You-Soo Park, Chi-Dug Kang & Jaeho Bae. (2021) Downregulation of NKG2DLs by TGF-β in human lung cancer cells. BMC Immunology 22:1.
Crossref
Haeryung Cho, Woo-Chang Son, Young-Shin Lee, Eun Jung Youn, Chi-Dug Kang, You-Soo Park & Jaeho Bae. (2021) Differential Effects of Histone Deacetylases on the Expression of NKG2D Ligands and NK Cell-Mediated Anticancer Immunity in Lung Cancer Cells. Molecules 26:13, pages 3952.
Crossref
Young‑Shin Lee, Woong Heo, Cheol‑Hun Son, Chi‑Dug Kang, You‑Soo Park & Jaeho Bae. (2019) Upregulation of Myc promotes the evasion of NK cell‑mediated immunity through suppression of NKG2D ligands in K562 cells. Molecular Medicine Reports.
Crossref
Young Shin Lee, Woong Heo, Jiho Nam, Young Hwa Jeung & Jaeho Bae. (2018) The combination of ionizing radiation and proteasomal inhibition by bortezomib enhances the expression of NKG2D ligands in multiple myeloma cells. Journal of Radiation Research 59:3, pages 245-252.
Crossref
Mingying Tang, Desmond Omane Acheampong, Youfu Wang, Wei Xie, Min Wang & Juan Zhang. (2016) Tumoral NKG2D alters cell cycle of acute myeloid leukemic cells and reduces NK cell-mediated immune surveillance. Immunologic Research 64:3, pages 754-764.
Crossref
Carolina Ribeiro, Karina Kramm, Felipe G�lvez-Jir�n, V�ctor Pola, Marco Bustamante, Hector Contreras, Andrea Sabag, Macarena Garrido-Tapia, Carolina Hern�ndez, Roberto Z��iga, Norberto Collazo, Pablo Sotelo, Camila Morales, Luis Mercado, Diego Catal�n, Juan Aguill�n & Mar�a Molina. (2015) Clinical significance of tumor expression of major histocompatibility complex class I-related chains A and B (MICA/B) in gastric cancer patients. Oncology Reports.
Crossref
WOONG HEO, YOUNG SHIN LEE, CHEOL HUN SON, KWANGMO YANG, YOU SOO PARK & JAEHO BAE. (2015) Radiation-induced matrix metalloproteinases limit natural killer cell-mediated anticancer immunity in NCI-H23 lung cancer cells. Molecular Medicine Reports 11:3, pages 1800-1806.
Crossref
So-Jung Kim, Ga-Hee Ha, Jae-Ho Bae, Ga Rim Kim, Cheol-Hun Son, You-Soo Park, Kwangmo Yang, Sae-Ock Oh, Sun-Hee Kim & Chi-Dug Kang. (2015) COX-2- and endoplasmic reticulum stress-independent induction of ULBP-1 and enhancement of sensitivity to NK cell-mediated cytotoxicity by celecoxib in colon cancer cells. Experimental Cell Research 330:2, pages 451-459.
Crossref
Cheol-Hun Son, Jin-Hee Keum, Kwangmo Yang, Jiho Nam, Mi-Ju Kim, Sun-Hee Kim, Chi-Dug Kang, Sae-Ock Oh, Chi-Dae Kim, You-Soo Park & Jaeho Bae. (2014) Synergistic enhancement of NK cell-mediated cytotoxicity by combination of histone deacetylase inhibitor and ionizing radiation. Radiation Oncology 9:1.
Crossref
Woong Heo, Young Shin Lee & Jaeho Bae. (2013) Inhibition of Oncogenes Affects the Expression of NKG2D Ligands in Cancer Cells. Journal of Life Science 23:10, pages 1216-1222.
Crossref
Jae-Ho Bae, So-Jung Kim, Mi-Ju Kim, Sae-Ock Oh, Joo-Seop Chung, Sun-Hee Kim & Chi-Dug Kang. (2012) Susceptibility to natural killer cell-mediated lysis of colon cancer cells is enhanced by treatment with epidermal growth factor receptor inhibitors through UL16-binding protein-1 induction. Cancer Science 103:1, pages 7-16.
Crossref
Benny Weiss-Steider, Isabel Soto-Cruz, Christian A Martinez-Campos & Jorge Flavio Mendoza-Rincon. (2011) Expression of MICA, MICB and NKG2D in human leukemic myelomonocytic and cervical cancer cells. Journal of Experimental & Clinical Cancer Research 30:1.
Crossref
Emilie Mamessier, Aude Sylvain, François Bertucci, Rémy Castellano, Pascal Finetti, Gilles Houvenaeghel, Emmanuelle Charaffe-Jaufret, Daniel Birnbaum, Alessandro Moretta & Daniel Olive. (2011) Human Breast Tumor Cells Induce Self-Tolerance Mechanisms to Avoid NKG2D-Mediated and DNAM-Mediated NK Cell Recognition. Cancer Research 71:21, pages 6621-6632.
Crossref
Julien Faget, Cathy Biota, Thomas Bachelot, Michael Gobert, Isabelle Treilleux, Nadège Goutagny, Isabelle Durand, Sophie Léon-Goddard, Jean Yves Blay, Christophe Caux & Christine Ménétrier-Caux. (2011) Early Detection of Tumor Cells by Innate Immune Cells Leads to Treg Recruitment through CCL22 Production by Tumor Cells. Cancer Research 71:19, pages 6143-6152.
Crossref
Jae-Ho Bae, Joo-Young Kim, Mi-Ju Kim, Sung-Ho Chang, You-Soo Park, Cheol-Hun Son, Soo-Jung Park, Joo-Seop Chung, Eun-Yup Lee, Sun-Hee Kim & Chi-Dug Kang. (2010) Quercetin Enhances Susceptibility to NK Cell-mediated Lysis of Tumor Cells Through Induction of NKG2D Ligands and Suppression of HSP70. Journal of Immunotherapy 33:4, pages 391-401.
Crossref
Espen Melum, Stephan Buch, Clemens Schafmayer, Holger Kalthoff, Jürgen Tepel, Stefan Schreiber, Tom H. Karlsen & Jochen Hampe. (2008) Investigation of cholangiocarcinoma associatedNKG2D polymorphisms in colorectal carcinoma. International Journal of Cancer 123:1, pages 241-242.
Crossref
Joo-Young Kim, Jae-Ho Bae, Sang-Hwa Lee, Eun-Yup Lee, Byung-Seon Chung, Sun-Hee Kim & Chi-Dug Kang. (2008) Induction of NKG2D Ligands and Subsequent Enhancement of NK Cell-mediated Lysis of Cancer Cells by Arsenic Trioxide. Journal of Immunotherapy 31:5, pages 475-486.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.